Yayın:
Preparation and in vitro evaluation of pyridostigmine bromide microparticles

dc.contributor.authorNahed Hegazy
dc.contributor.authorHegazy, Nahed
dc.contributor.authorMüzeyyen Demirel
dc.contributor.authorDEMİREL, MÜZEYYEN
dc.contributor.authorYasemin Yazan
dc.contributor.authorYazan, Yasemin
dc.contributor.orcid0000-0001-9927-683X
dc.date.accessioned2025-11-13T10:12:01Z
dc.date.issued2002-08-01
dc.identifier.doi10.1016/s0378-5173(02)00146-1
dc.identifier.endpage174
dc.identifier.issn0378-5173
dc.identifier.issue1-2
dc.identifier.openalexW2159533642
dc.identifier.pubmed12176241
dc.identifier.scopus2-s2.0-0037151532
dc.identifier.startpage171
dc.identifier.urihttps://hdl.handle.net/11421/3424
dc.identifier.urihttps://doi.org/10.1016/s0378-5173(02)00146-1
dc.identifier.volume242
dc.identifier.wos000179539900023
dc.language.isoen
dc.relation.ispartofInternational Journal of Pharmaceutics
dc.rightsrestrictedAccess
dc.subjectPyridostigmine Bromide
dc.subjectActive ingredient
dc.subjectDosage form
dc.subjectSolubility
dc.subjectChemistry
dc.subjectChromatography
dc.subjectMicroparticle
dc.subjectPyridostigmine
dc.subjectPolymer
dc.subjectDrug
dc.subjectParticle size
dc.subjectPharmacology
dc.subjectChemical engineering
dc.subjectOrganic chemistry
dc.subjectMyasthenia gravis
dc.subjectMedicine
dc.titlePreparation and in vitro evaluation of pyridostigmine bromide microparticles
dc.typeArticle
dspace.entity.typePublication
local.authorid.openalexA5079517584
local.authorid.openalexA5025148207
local.authorid.openalexA5005967372

Dosyalar

Koleksiyonlar